株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

中国の生命保険:主な動向と機会

China Life Insurance: Key trends and Opportunities to 2022

発行 GlobalData 商品コード 923013
出版日 ページ情報 英文 53 Pages
即納可能
価格
本日の銀行送金レート: 1USD=110.94円で換算しております。
Back to Top
中国の生命保険:主な動向と機会 China Life Insurance: Key trends and Opportunities to 2022
出版日: 2020年01月10日 ページ情報: 英文 53 Pages
概要

当レポートでは、中国の生命保険セグメントについて調査分析し、製品カテゴリー別の見通しに焦点を当てて、主要業績評価指標 (KPI) 、普及率、流通チャネル、競合情勢、主要企業などについて、体系的な情報を提供しています。

第1章 エグゼクティブサマリー

第2章 経済の概要

第3章 サマリー動向とKPI

  • 普及率と成長率
  • 消費者セグメントと保持
  • 保険料と請求
  • 資産と投資

第4章 規制リスク

  • 進化
  • 主な要因
  • ライセンス要件

第5章 主な動向:LOB (事業部門) 別 - 消費者セグメント

  • 小売生命保険
  • 商業生命保険

第6章 主な動向:LOB (事業部門) 別 - KPI、市場シェア、集中

  • 生命保険
  • 年金

第7章 流通の概要

  • 流通経路の概要

第8章 競合情勢

  • 生命保険市場シェア
  • 主なM&A取引

第9章 競合企業プロファイル

第10章 InsurTech

第11章 付録

目次
Product Code: GDIS2018MR

GlobalData's 'China Life Insurance: Key Trends and Opportunities to 2022' report provides in-depth market analysis, information and insights into the Chinese life insurance segment.

This report provides a detailed outlook by product category for the Chinese life insurance segment.

It provides values for key performance indicators such as gross written premium, claims paid, penetration and assets during the review period (2013-2017) and forecast period (2017-2022).

The report gives a comprehensive overview of the Chinese economy and demographics, and provides detailed information on the competitive landscape in the country.

The report brings together GlobalData's research, modeling and analysis expertise, giving insurers access to information on segment dynamics and competitive advantages, and profiles of insurers operating in the country. The report also includes details of insurance regulations, and recent changes in the regulatory structure.

Key Highlights:

  • Key insights into the dynamics of the Chinese life insurance industry.
  • Comparison of Chinese life insurance segments, along with premium and claim trends.
  • A comprehensive overview of the Chinese economy, government initiatives and investment opportunities.
  • Chinese insurance regulatory framework's evolution, key facts, taxation regime, licensing and capital requirements.
  • Chinese life insurance industry's market structure giving details of retail and commercial lines of business.
  • Details of the competitive landscape, M&A and competitors' profiles.

Scope:

This report provides a comprehensive analysis of the life insurance segment in China -

  • It provides historical values for the Chinese life insurance segment for the report's 2013-2017 review period, and projected figures for the 2017-2022 forecast period.
  • It offers a detailed analysis of the key categories in the Chinese life insurance segment, and market forecasts to 2022.
  • It profiles the top life insurance companies in China and outlines the key regulations affecting them.

Reasons to buy:

  • Make strategic business decisions using in-depth historic and forecast market data related to Chinese life insurance segment, and each category within it.
  • Understand the demand-side dynamics, key market trends and growth opportunities in the Chinese life insurance segment.
  • Assess the competitive dynamics in the life insurance segment.
  • Identify growth opportunities and market dynamics in key product categories.

Table of Contents

Chapter 1 Executive Summary

Chapter 2 Economy Overview

Chapter 3 Summary Trend and KPIs

  • Penetration and Growth
  • Consumer Segment and Retention
  • Premiums and Claims
  • Assets and Investment

Chapter 4 Regulatory Risk

  • Evolution
  • Key Facts
  • Licensing Requirements

Chapter 5 Key Trends by Lines of Business - Consumer Segment

  • Retail Life Insurance
  • Commercial Life Insurance

Chapter 6 Key Trends by Lines of Business - KPIs, Market Share and Concentration

  • Life Insurance
  • Pension

Chapter 7 Distribution Overview

  • Distribution Channel Overview

Chapter 8 Competitive Landscape

  • Life Insurance Market Share
  • Key M&As Transactions

Chapter 9 Competitor Profiles

Chapter 10 Insurtech

Chapter 11 Appendix

Back to Top